Brivaracetam

CAS 357336-20-0 25 current recordsSmall Molecule

Who holds supplier records for Brivaracetam? 25 organisations hold a current record for Brivaracetam: an active US FDA Type II Drug Master File or a CEP. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13) and China (7); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Brivaracetam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/brivaracetam

Reading the evidence

  • 25 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    13 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 14 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Brivaracetam expires 9 Apr 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (25)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Brivaracetam. Country is the organisation's recorded country, not necessarily the manufacturing site.

India13China7Country not recorded for 5
  • AMI LIFESCIENCES PRIVATE LTD
    Active DMF 36655, 41918 · latest filing May 2025
    IndiaCEP Company GMP cert on record
  • HONOUR LAB LTD
    Active DMF 34569, 42544 · latest filing Sept 2025
    IndiaCEP Company GMP cert on record
  • Yangzhou Aurisco Pharmaceutical Co.,Ltd.
    Active DMF 37329, 40342 · latest filing Sept 2024
    ChinaCEP
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
    Active DMF 37524, 40761 · latest filing Oct 2024
    ChinaCEP Company GMP cert on record
  • ALIVUS LIFE SCIENCES LTD
    Active DMF 38597 · latest filing Nov 2023
    IndiaCEP Company GMP cert on record
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 40678 · latest filing Dec 2024
    IndiaCEP Company GMP cert on record
  • Chengda Pharmaceuticals Co., Ltd.
    Active DMF 37821 · latest filing Jul 2023
    ChinaCEP
  • Divis Laboratories
    Active DMF 41570 · latest filing Mar 2025
    IndiaCEP Company GMP cert on record
  • LEE PHARMA LTD
    Active DMF 39008 · latest filing Oct 2023
    IndiaCEP Company GMP cert on record
  • Maithri Laboratories Private Limited
    Active DMF 33709 · latest filing Mar 2019
    IndiaCEP Company GMP cert on record
  • MICRO LABS LTD
    Active DMF 34585 · latest filing Feb 2020
    IndiaCEP Company GMP cert on record
  • OPTIMUS DRUGS PRIVATE LTD
    Active DMF 36649 · latest filing Apr 2022
    IndiaCEP
  • SOLARA ACTIVE PHARMA SCIENCES LTD
    Active DMF 36304 · latest filing Sept 2021
    IndiaCEP Company GMP cert on record
  • ATILUS PHARMA PRIVATE LTD
    Active DMF 44646 · latest filing Aug 2026
  • Aurisco Pharmaceutical Co.,ltd
    Active DMF 34511 · latest filing Jan 2020
    China Company GMP cert on record
  • BEIJING HOPE PHARMACEUTICAL CO LTD
    Active DMF 37516 · latest filing Sept 2022
  • CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
    Active DMF 41491 · latest filing Mar 2025
    Company GMP cert on record
  • EMNAR PHARMA PRIVATE LTD
    Active DMF 44011 · latest filing Apr 2026
    India
  • LUPIN MANUFACTURING SOLUTIONS LTD
    Active DMF 34402 · latest filing Dec 2019
  • MAITHRI DRUGS PRIVATE LTD
    Active DMF 44123 · latest filing May 2026
    India Company GMP cert on record
  • RUYUAN HEC PHARM CO LTD
    Active DMF 34398 · latest filing Jan 2020
  • Shaoxing Jingxin Pharmaceutical Co., Ltd.
    Active DMF 36409 · latest filing Dec 2021
    China
  • Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
    Active DMF 42511 · latest filing Sept 2025
    China
  • Zydus Lifesciences Limited
    Active DMF 34405 · latest filing Dec 2019
    India Company GMP cert on record
  • ChinaCEP
Need Brivaracetam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Brivaracetam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HONOUR LAB LIMITED HyderabadIN
CEP 2024-533 - Rev 00
Brivaracetam
Nov 2026—
AMI LIFESCIENCES PRIVATE LIMITED VadodaraIN
CEP 2025-171 - Rev 01
Brivaracetam, Process II
Nov 2026Inspected Oct 2025
Slovakia
LEE PHARMA LIMITED HyderabadIN
CEP 2024-474 - Rev 00
Brivaracetam
Sept 2026—
OPTIMUS DRUGS PRIVATE LIMITED HyderabadIN
CEP 2025-132 - Rev 00
Brivaracetam
Aug 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2024-596 - Rev 01
Brivaracetam, Form-A
Jul 2026—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2024-186 - Rev 00
Brivaracetam
Jun 2026—
DIVI'S LABORATORIES LIMITED HyderabadIN
CEP 2025-021 - Rev 00
Brivaracetam
Jun 2026—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2025-089 - Rev 01
Brivaracetam
May 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2024-088 - Rev 02
Brivaracetam
May 2026—
MICRO LABS LIMITED BengaluruIN
CEP 2025-533 - Rev 00
Brivaracetam, Process-II
Mar 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2024-064 - Rev 02
Brivaracetam, Non-micronised and micronised
Feb 2026Inspected May 2026
Italy
CHENGDA PHARMACEUTICALS CO., LTD. JiashanCN
CEP 2024-227 - Rev 00
Brivaracetam
Dec 2025—
MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam VillageIN
CEP 2024-061 - Rev 01
Brivaracetam, Micronised and Non-micronised
Jul 2025—
YANGZHOU AURISCO PHARMACEUTICAL CO., LTD. Yangzhou CityCN
CEP 2024-375 - Rev 00
Brivaracetam
Mar 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (56 listed products contain Brivaracetam). The latest listed patent expires 9 Apr 2030. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Brivaracetam is an anticonvulsant medication used to treat epilepsy. It is a derivative of levetiracetam with a racetam chemical structure.

Chemical identity

IUPAC name
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
Canonical SMILES
CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N
InChIKey
MSYKRHVOOPPJKU-BDAKNGLRSA-N
Synonyms
Briviact API, briviact, dea no. 2710, ucb 34714

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Mechanism of action
Epoxide Hydrolase Inhibitors

Therapeutic areas

NeurologyEpilepsy

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Brivaracetam?

25 organisations hold an active US FDA Type II Drug Master File or a CEP for Brivaracetam: AMI LIFESCIENCES PRIVATE LTD (India), HONOUR LAB LTD (India), Yangzhou Aurisco Pharmaceutical Co.,Ltd. (China), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Chengda Pharmaceuticals Co., Ltd. (China) and Divis Laboratories (India), and 17 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Brivaracetam Drug Master Files are active?

AMI LIFESCIENCES PRIVATE LTD (DMF 36655, 41918), HONOUR LAB LTD (DMF 34569, 42544), Yangzhou Aurisco Pharmaceutical Co.,Ltd. (DMF 37329, 40342), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 37524, 40761), ALIVUS LIFE SCIENCES LTD (DMF 38597), APITORIA PHARMA PRIVATE LTD (DMF 40678), Chengda Pharmaceuticals Co., Ltd. (DMF 37821) and Divis Laboratories (DMF 41570) and 16 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Brivaracetam have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Brivaracetam on the EDQM register, including HONOUR LAB LIMITED Hyderabad (IN), AMI LIFESCIENCES PRIVATE LIMITED Vadodara (IN), LEE PHARMA LIMITED Hyderabad (IN), OPTIMUS DRUGS PRIVATE LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Brivaracetam?

Yes. The latest patent listed for an approved US product containing Brivaracetam expires 9 Apr 2030, across 56 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Brivaracetam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Brivaracetam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.